Jean-pierre P. Lindenmayer

Psychiatry

18 E 77th St
New York, NY 10075

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Psychometric analysis of speech-based digital biomarkers of alogia symptoms in treatment resistant schizophrenia: Comparison with clinical ratings of expressive negative symptoms.

Psychometric analysis of speech-based digital biomarkers of alogia symptoms in treatment resistant schizophrenia: Comparison with clinical ratings of expressive negative symptoms.

Journal: Schizophrenia research

Published: December 15, 2025

Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled Trial.

Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled Trial.

Journal: JMIR research protocols

Published: July 25, 2025

Tardive dyskinesia versus tardive syndrome. What is in a name?

Tardive dyskinesia versus tardive syndrome. What is in a name?

Journal: Parkinsonism & related disorders

Published: October 09, 2024

Late Recognition of Cholinergic Delirium in Patient on Donepezil Combination Treatment.

Late Recognition of Cholinergic Delirium in Patient on Donepezil Combination Treatment.

Journal: Journal of clinical psychopharmacology

Published: August 15, 2024

Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia.

Sustained Treatment Response and Global Improvements With Long-term Valbenazine in Patients With Tardive Dyskinesia.

Journal: Journal of clinical psychopharmacology

Published: May 20, 2024

SIBAT-A Computerized Assessment Tool for Suicide Ideation and Behavior: Development and Psychometric Properties.

SIBAT-A Computerized Assessment Tool for Suicide Ideation and Behavior: Development and Psychometric Properties.

Journal: Innovations in clinical neuroscience

Published: August 12, 2022

Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Journal: Schizophrenia bulletin

Published: July 12, 2022

Computerized cognitive and social cognition training in schizophrenia for impulsive aggression.

Computerized cognitive and social cognition training in schizophrenia for impulsive aggression.

Journal: Schizophrenia research

Published: May 20, 2022

Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.

Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.

Journal: JAMA network open

Published: May 06, 2022

Phase 3b Multicenter, Prospective, Open-label Trial to Evaluate the Effects of a Digital Medicine System on Inpatient Psychiatric Hospitalization Rates for Adults With Schizophrenia.

Phase 3b Multicenter, Prospective, Open-label Trial to Evaluate the Effects of a Digital Medicine System on Inpatient Psychiatric Hospitalization Rates for Adults With Schizophrenia.

Journal: The Journal of clinical psychiatry

Published: April 14, 2022

Healthcare Provider Engagement with a Novel Dashboard for Tracking Medication Ingestion: Impact on Treatment Decisions and Clinical Assessments for Adults with Schizophrenia.

Healthcare Provider Engagement with a Novel Dashboard for Tracking Medication Ingestion: Impact on Treatment Decisions and Clinical Assessments for Adults with Schizophrenia.

Journal: Neuropsychiatric disease and treatment

Published: April 08, 2022

Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia.

Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia.

Journal: Patient preference and adherence

Published: February 23, 2022

Showing 1-12 of 71

Last Updated: 09/26/2026